Dipl.-Biochem., Ph.D. (Univ. Cambridge), British and European Patent Attorney
Languages: English, French, German, Spanish
Oppositions and appeals before the European Patent Office; EPO oral proceedings; patent prosecution before the EPO and UK-IPO and coordinating the prosecution of patent portfolios worldwide; drafting and advising on new patent applications. Opinion work, including freedom to operate and patentability opinions; due diligence. Experience across the life sciences (biotechnology and pharmaceuticals), including molecular biology, biochemistry, medical inventions, diagnostic methods and products, research tools; e.g., cancer biology, transgenic animals, cell and tissue culture, cell therapy, antibodies, protein and peptide therapeutics, oligonucleotide agents. Particular expertise in the area of RNA and other nucleic acid-based technologies, e.g. RNAi, antisense, nucleic acid modifications.
Studied biochemistry at the Universities of Regensburg and Oxford (research with Sir Jack Baldwin in organic chemistry, enzymology and structural biology). PhD on the structure and function of the ribosome with Venki Ramakrishnan at the University of Cambridge closely connected with Ramakrishnan’s Nobel Prize for Chemistry 2009. Scientific publications on this topic e.g. in Science, Cell, and Annual Reviews of Biochemistry, and lectures at Cambridge University. Fellow of Trinity College, Cambridge; scholar of the Boehringer Ingelheim Foundation, the UK Medical Research Council, the Studienstiftung des Deutschen Volkes and under the Bavarian Act for Promoting Highly Gifted Students. Joined HOFFMANN EITLE in 2004. Trained and worked with a leading IP law firm in London (2006-2012). European Patent Attorney since 2008, British Chartered Patent Attorney since 2009.